1. Home
  2. AMP vs KVUE Comparison

AMP vs KVUE Comparison

Compare AMP & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMP
  • KVUE
  • Stock Information
  • Founded
  • AMP 1894
  • KVUE 2022
  • Country
  • AMP United States
  • KVUE United States
  • Employees
  • AMP N/A
  • KVUE N/A
  • Industry
  • AMP Investment Managers
  • KVUE Specialty Chemicals
  • Sector
  • AMP Finance
  • KVUE Consumer Discretionary
  • Exchange
  • AMP Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • AMP 54.5B
  • KVUE 46.2B
  • IPO Year
  • AMP 2005
  • KVUE 2023
  • Fundamental
  • Price
  • AMP $532.00
  • KVUE $21.78
  • Analyst Decision
  • AMP Buy
  • KVUE Hold
  • Analyst Count
  • AMP 10
  • KVUE 13
  • Target Price
  • AMP $489.00
  • KVUE $22.67
  • AVG Volume (30 Days)
  • AMP 552.9K
  • KVUE 13.6M
  • Earning Date
  • AMP 01-22-2025
  • KVUE 02-06-2025
  • Dividend Yield
  • AMP 1.11%
  • KVUE 3.77%
  • EPS Growth
  • AMP 0.58
  • KVUE N/A
  • EPS
  • AMP 26.03
  • KVUE 0.55
  • Revenue
  • AMP $17,445,000,000.00
  • KVUE $15,459,000,000.00
  • Revenue This Year
  • AMP $6.35
  • KVUE $2.89
  • Revenue Next Year
  • AMP $6.54
  • KVUE $2.80
  • P/E Ratio
  • AMP $20.44
  • KVUE $39.39
  • Revenue Growth
  • AMP 11.49
  • KVUE N/A
  • 52 Week Low
  • AMP $368.41
  • KVUE $17.67
  • 52 Week High
  • AMP $577.00
  • KVUE $24.46
  • Technical
  • Relative Strength Index (RSI)
  • AMP 39.84
  • KVUE 32.80
  • Support Level
  • AMP $521.77
  • KVUE $21.42
  • Resistance Level
  • AMP $546.72
  • KVUE $22.48
  • Average True Range (ATR)
  • AMP 9.77
  • KVUE 0.60
  • MACD
  • AMP -5.34
  • KVUE -0.18
  • Stochastic Oscillator
  • AMP 22.25
  • KVUE 12.81

About AMP Ameriprise Financial Inc.

Ameriprise Financial is a major player in the us market for asset and wealth management, with around $1.4 trillion in total assets under management and administration at the end of 2023. With about 10,000 advisors, Ameriprise has one of the largest branded advisor networks in the industry. About 80% of the company's revenue comes from its asset and wealth management segments. Ameriprise has reduced its exposure to insurance with the sale of its auto and home insurance business in 2019 and discontinuing the sale of proprietary fixed annuities in 2020.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: